Search

everythinglearnresearchcommunity

for

Search:↓

Monilethrix is a genetic hair disorder causing fragile, beaded hair with no effective treatment.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Pantotherapy is more effective for treating androgenetic alopecia than darsonvalization.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.